Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis

Not Applicable

• Conditions: nongonococcal urethritis (Chlamydia trachomatis urethritis, Mycoplasma genitalium urethritis)

• Registration Number: JPRN-UMIN000003897
• Lead Sponsor: Department of Infectious Diseases and Infection Control, Jikei University School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-07-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1)patient detected N.gonorrhoeae by microscopic examination or bacteriological examination etc. 2)patient who has been administered other antibiotics and his symptom has been improved before starting administration of the study drug 3)patient administered fluoroquinolone within a week before starting administration of the study drug 4)patient with severe infection desease, who cannot be expected efficacy of oral administration therapy 5)patient with severe underlying disease or complications, who cannot be evaluated efficacy and safety of the study drug 6)patient with a history of fluoroquinolone allergies 7)patient with severe cardiac or hepatic dysfunction 8)patient with moderate renal dysfunction (Criteria: Serum Creatinine >= 2mg/dL) 9)patient with convulsive disorders like epilepsy or with a history of these deseases 10)patient disqualified as target by doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified